(Total Views: 443)
Posted On: 10/21/2018 11:51:16 AM
Post# of 9144
publication in the eu journal- following a ca 9 month period during which the patents could be legally challenged - did not occur til ca April 10-11
until then big companies dd of nnlx and the product might be considered by many such companies to be a gamble
so, if beyond an expression of interest,to e.g., make sure nnlx did not make an exclusive deal w a competitor,such big co's did not begin serious dd til apr 11,it could be a while
nowadays big co's leave nothing to chance and their dd is seriously big time-that dd includes the cost benefit analysis of increased risk of lawsuits if they dont have the best product available
the distribution system and changes to such are micro analyzed also
then estimated future sales have to be discounted to arrive at net present value for the venture
then big co's start by offering a ridiculously low net present value-
and then the fun begins of arduous negotiation where big co's try to take advantage of small companies via unacceptable monetary and control issues,which is probably why previous incipient adventures did not produce the expected fruit
complicated in the case of biotech
bc at least 3-4 different groups of people-lawyers ,business people and scientists and doctors- who all speak different languages (not even talking about english vs german and cultural idiosyncracies) have to bridge the language gap to actually communicate w each other both internally and externally-a major feat in our overspecialized world
nothing i havent said before- so reading past posts could be profitable -this is just a bare bones outline
as i've said the average time to create a jv relationship is 18-36 months
partly bc everything is done by committee- which is the death knell to progress
getting more than 2 ppl to agree to such simple things as choosing a restaurant or movie can be a challenge in todays purposefully complicated world
licensing might be the fastest route and a trial run prior to purchase bc it safeguards both parties-less risk to both parties-both parties feel like they have some guarantees
some companies exist just to license their products -like fnjn- and make their money by suing co's who are using their product without a license
so we are still in the typical early stages re these things and if serious negotiations didnt begin til apr 11,we are just now still in the licensing window, to be followed typically time wise by a sale, and then jv deal - if things go according to boyle
in such early stages big co's demand the utmost secrecy- thus 500pp nda's by big co lawyer committee- a death knell of death knells re speed
in todays world,for small companies who dont have experience w this tedious process,small companies reaction would typically be - "you got to be kidding me", and either capitulate or walkaway in disgust
fortunately, nnlx has a few rodeos under its belt re these things, which bodes well for a fair realistic agreement that doesnt succumb to big co's demand for total ripoff and total control
until then big companies dd of nnlx and the product might be considered by many such companies to be a gamble
so, if beyond an expression of interest,to e.g., make sure nnlx did not make an exclusive deal w a competitor,such big co's did not begin serious dd til apr 11,it could be a while
nowadays big co's leave nothing to chance and their dd is seriously big time-that dd includes the cost benefit analysis of increased risk of lawsuits if they dont have the best product available
the distribution system and changes to such are micro analyzed also
then estimated future sales have to be discounted to arrive at net present value for the venture
then big co's start by offering a ridiculously low net present value-
and then the fun begins of arduous negotiation where big co's try to take advantage of small companies via unacceptable monetary and control issues,which is probably why previous incipient adventures did not produce the expected fruit
complicated in the case of biotech
bc at least 3-4 different groups of people-lawyers ,business people and scientists and doctors- who all speak different languages (not even talking about english vs german and cultural idiosyncracies) have to bridge the language gap to actually communicate w each other both internally and externally-a major feat in our overspecialized world
nothing i havent said before- so reading past posts could be profitable -this is just a bare bones outline
as i've said the average time to create a jv relationship is 18-36 months
partly bc everything is done by committee- which is the death knell to progress
getting more than 2 ppl to agree to such simple things as choosing a restaurant or movie can be a challenge in todays purposefully complicated world
licensing might be the fastest route and a trial run prior to purchase bc it safeguards both parties-less risk to both parties-both parties feel like they have some guarantees
some companies exist just to license their products -like fnjn- and make their money by suing co's who are using their product without a license
so we are still in the typical early stages re these things and if serious negotiations didnt begin til apr 11,we are just now still in the licensing window, to be followed typically time wise by a sale, and then jv deal - if things go according to boyle
in such early stages big co's demand the utmost secrecy- thus 500pp nda's by big co lawyer committee- a death knell of death knells re speed
in todays world,for small companies who dont have experience w this tedious process,small companies reaction would typically be - "you got to be kidding me", and either capitulate or walkaway in disgust
fortunately, nnlx has a few rodeos under its belt re these things, which bodes well for a fair realistic agreement that doesnt succumb to big co's demand for total ripoff and total control
(0)
(0)
